Search

Your search keyword '"Duncan, Christopher J. A."' showing total 333 results
Start Over Author "Duncan, Christopher J. A."
333 results on '"Duncan, Christopher J. A."'

1. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history

Author

Hornsby, Hailey, Nicols, Alexander R., Longet, Stephanie, Liu, Chang, Tomic, Adriana, Angyal, Adrienn, Kronsteiner, Barbara, Tyerman, Jessica K., Tipton, Tom, Zhang, Peijun, Gallis, Marta, Supasa, Piyada, Selvaraj, Muneeswaran, Abraham, Priyanka, Neale, Isabel, Ali, Mohammad, Barratt, Natalie A., Nell, Jeremy M., Gustafsson, Lotta, Strickland, Scarlett, Grouneva, Irina, Rostron, Timothy, Moore, Shona C., Hering, Luisa M., Dobson, Susan L., Bibi, Sagida, Mongkolsapaya, Juthathip, Lambe, Teresa, Wootton, Dan, Hall, Victoria, Hopkins, Susan, Dong, Tao, Barnes, Eleanor, Screaton, Gavin, Richter, Alex, Turtle, Lance, Rowland-Jones, Sarah L., Carroll, Miles, Duncan, Christopher J. A., Klenerman, Paul, Dunachie, Susanna J., Payne, Rebecca P., and de Silva, Thushan I.

Published
2023
Full Text
View/download PDF

2. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

Author

Bethune, Claire, Boffito, Marta, Browne, Duncan, Bula, Marcin, Burns, Fiona, Chadwick, David, Clark, Rebecca, Cosgrove, Catherine A., Dargan, Paul I., Darton, Thomas C., Duncan, Christopher J.A., Emmett, Stevan, Galiza, Eva P., Galloway, James, Heath, Paul T., Jones, Lucy, Kalra, Philip A., Kaminski, Rachel, Lazarus, Rajeka, Lillie, Patrick J., Moore, Patrick, Moran, Ed, Nally, Rhiannon, Palfreeman, Adrian, Ramos, Alberto San Francisco, Rampling, Tommy, Sahdev, Anju, Saralaya, Dinesh, Sheridan, Ray, Soiza, Roy, Lee, Ivan T, Cosgrove, Catherine A, Kalra, Philip A, Dargan, Paul I, Darton, Thomas C, Duncan, Christopher J A, Lillie, Patrick J, San Francisco Ramos, Alberto, Galiza, Eva P, Heath, Paul T, Girard, Bethany, Parker, Christy, Rust, Dondi, Mehta, Shraddha, de Windt, Elizabeth, Sutherland, Andrea, Tomassini, Joanne E, Dutko, Frank J, Chalkias, Spyros, Deng, Weiping, Chen, Xing, Feng, Jing, Tracy, LaRee, Zhou, Honghong, Miller, Jacqueline M, and Das, Rituparna

Published
2023
Full Text
View/download PDF

3. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Author

Stuart, Arabella S V, Shaw, Robert H, Liu, Xinxue, Greenland, Melanie, Aley, Parvinder K, Andrews, Nick J, Cameron, J C, Charlton, Sue, Clutterbuck, Elizabeth A, Collins, Andrea M, Darton, Tom, Dinesh, Tanya, Duncan, Christopher J A, England, Anna, Faust, Saul N, Ferreira, Daniela M, Finn, Adam, Goodman, Anna L, Green, Christopher A, Hallis, Bassam, Heath, Paul T, Hill, Helen, Horsington, Bryn M, Lambe, Teresa, Lazarus, Rajeka, Libri, Vincenzo, Lillie, Patrick J, Mujadidi, Yama F, Payne, Ruth, Plested, Emma L, Provstgaard-Morys, Samuel, Ramasamy, Maheshi N, Ramsay, Mary, Read, Robert C, Robinson, Hannah, Screaton, Gavin R, Singh, Nisha, Turner, David P J, Turner, Paul J, Vichos, Iason, White, Rachel, Nguyen-Van-Tam, Jonathan S, and Snape, Matthew D

Published
2022
Full Text
View/download PDF

4. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study

Author

Manson, Jessica J, Crooks, Colin, Naja, Meena, Ledlie, Amanda, Goulden, Bethan, Liddle, Trevor, Khan, Emon, Mehta, Puja, Martin-Gutierrez, Lucia, Waddington, Kirsty E, Robinson, George A, Ribeiro Santos, Liliana, McLoughlin, Eve, Snell, Antonia, Adeney, Christopher, Schim van der Loeff, Ina, Baker, Kenneth F, Duncan, Christopher J A, Hanrath, Aidan T, Lendrem, B Clare, De Soyza, Anthony, Peng, Junjie, J'Bari, Hajar, Greenwood, Mandy, Hawkins, Ellie, Peckham, Hannah, Marks, Michael, Rampling, Tommy, Luintel, Akish, Williams, Bryan, Brown, Michael, Singer, Mervyn, West, Joe, Jury, Elizabeth C, Collin, Matthew, and Tattersall, Rachel S

Published
2020
Full Text
View/download PDF

5. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2

Author

Hatton, Catherine F., Botting, Rachel A., Dueñas, Maria Emilia, Haq, Iram J., Verdon, Bernard, Thompson, Benjamin J., Spegarova, Jarmila Stremenova, Gothe, Florian, Stephenson, Emily, Gardner, Aaron I., Murphy, Sandra, Scott, Jonathan, Garnett, James P., Carrie, Sean, Powell, Jason, Khan, C. M. Anjam, Huang, Lei, Hussain, Rafiqul, Coxhead, Jonathan, Davey, Tracey, Simpson, A. John, Haniffa, Muzlifah, Hambleton, Sophie, Brodlie, Malcolm, Ward, Chris, Trost, Matthias, Reynolds, Gary, and Duncan, Christopher J. A.

Published
2021
Full Text
View/download PDF

7. Macrophage transplantation rescues RNASET2-deficient leukodystrophy by replacing deficient microglia in a zebrafish model.

Author

Rutherford, A., Candeias, Diogo, Duncan, Christopher J. A., Renshaw, Stephen A., and Hamilton, Noémie

Subjects
MICROGLIA, LEUKODYSTROPHY, BRACHYDANIO, MACROPHAGES, WHITE matter (Nerve tissue), RESCUE work, FIRE resistant polymers
Abstract

RNASET2-deficient leukodystrophy is a rare infantile white matter disorder mimicking a viral infection and resulting in severe psychomotor impairments. Despite its severity, there is little understanding of cellular mechanisms of pathogenesis and no treatments. Recent research using the rnaset2 mutant zebrafish model has suggested that microglia may be the drivers of the neuropathology, due to their failure to digest apoptotic debris during neurodevelopment. Therefore, we developed a strategy for microglial replacement through transplantation of adult whole kidney marrow-derived macrophages into embryonic hosts. Using live imaging, we revealed that transplant-derived macrophages can engraft within host brains and express microglia-specific markers, suggesting the adoption of a microglial phenotype. Tissue-clearing strategies revealed the persistence of transplanted cells in host brains beyond embryonic stages. We demonstrated that transplanted cells clear apoptotic cells within the brain, as well as rescue overactivation of the antiviral response otherwise seen in mutant larvae. RNA sequencing at the point of peak transplant-derived cell engraftment confirms that transplantation can reduce the brain-wide immune response and particularly, the antiviral response, in rnaset2-deficient brains. Crucially, this reduction in neuroinflammation resulted in behavioral rescue--restoring rnaset2 mutant motor activity to wild-type (WT) levels in embryonic and juvenile stages. Together, these findings demonstrate the role of microglia as the cellular drivers of neuropathology in rnaset2 mutants and that macrophage transplantation is a viable strategy for microglial replacement in the zebrafish. Therefore, microglia-targeted interventions may have therapeutic benefits in RNASET2-deficient leukodystrophy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. 2363. Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial

Author

Lee, Ivan T, primary, Cosgrove, Catherine A, additional, Moore, Patrick, additional, Bula, Marcin, additional, Kalra, Philip, additional, Dargan, Paul, additional, Clark, Rebecca, additional, Boffito, Marta, additional, Sheridan, Ray, additional, Bethune, Claire, additional, Burns, Fiona, additional, Saralaya, Dinesh, additional, Nally, Rhiannon, additional, Duncan, Christopher J A, additional, Chadwick, David, additional, Palfreeman, Adrian, additional, Ramos, Alberto San Francisco, additional, Heath, Paul T, additional, Girard, Bethany, additional, Sellers, Kristen, additional, de Windt, Elizabeth, additional, Sutherland, Andrea, additional, Tracy, LaRee, additional, Zhou, Honghong, additional, Miller, Jacqueline, additional, Priddy, Frances, additional, Chalkias, Spyros, additional, and Das, Rituparna, additional

Published
2023
Full Text
View/download PDF

9. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

Author

Lee, Ivan T, primary, Cosgrove, Catherine A, additional, Moore, Patrick, additional, Bethune, Claire, additional, Nally, Rhiannon, additional, Bula, Marcin, additional, Kalra, Philip A, additional, Clark, Rebecca, additional, Dargan, Paul I, additional, Boffito, Marta, additional, Sheridan, Ray, additional, Moran, Ed, additional, Darton, Thomas C, additional, Burns, Fiona, additional, Saralaya, Dinesh, additional, Duncan, Christopher J A, additional, Lillie, Patrick J, additional, San Francisco Ramos, Alberto, additional, Galiza, Eva P, additional, Heath, Paul T, additional, Girard, Bethany, additional, Parker, Christy, additional, Rust, Dondi, additional, Mehta, Shraddha, additional, de Windt, Elizabeth, additional, Sutherland, Andrea, additional, Tomassini, Joanne E, additional, Dutko, Frank J, additional, Chalkias, Spyros, additional, Deng, Weiping, additional, Chen, Xing, additional, Feng, Jing, additional, Tracy, LaRee, additional, Zhou, Honghong, additional, Miller, Jacqueline M, additional, Das, Rituparna, additional, Browne, Duncan, additional, Chadwick, David, additional, Cosgrove, Catherine A., additional, Dargan, Paul I., additional, Darton, Thomas C., additional, Duncan, Christopher J.A., additional, Emmett, Stevan, additional, Galiza, Eva P., additional, Galloway, James, additional, Heath, Paul T., additional, Jones, Lucy, additional, Kalra, Philip A., additional, Kaminski, Rachel, additional, Lazarus, Rajeka, additional, Lillie, Patrick J., additional, Palfreeman, Adrian, additional, Ramos, Alberto San Francisco, additional, Rampling, Tommy, additional, Sahdev, Anju, additional, and Soiza, Roy, additional

Published
2023
Full Text
View/download PDF

10. Macrophage-CD4⁺ T cell interactions in HIV-1 spread

Author

Duncan, Christopher J. A., Sattentau, Quentin J., McMichael, Andrew J., and Moore, Rebecca

Subjects
616.07, Life Sciences, HIV/AIDS, Medical Sciences
Abstract

Macrophages and CD4+ T cells are the main targets for productive human immunodeficiency virus-1 (HIV-1) infection in vivo. HIV-1 transmission at immune cell synapses, such as the multi-molecular HIV-1-induced virological synapse (VS) formed between T cells, is a more efficient method of viral dissemination than infection by cell-free virus, with important implications for HIV-1 prophylaxis and eradication. Infected macrophages can transfer HIV-1 to CD4+ T cells in a contact- dependent manner. However, the mechanism(s) of intercellular HIV-1 transmission between primary macrophages and CD4+ T cells are poorly defined. Here I investigate the organisation of the macrophage-T cell VS, which like the VS formed between T cells is dependent on envelope glycoprotein (Env) binding to CD4, and is stabilised by ICAM-1/LFA-1 interactions. However, unlike the T cell VS, where polarised budding of virions occurs at the donor cell membrane, VS-transmission from macrophages involves actin-dependent relocation of HIV-1 contained within the macrophage virus-containing compartment. Macrophage VS-mediated transmission results in highly efficient productive T cell infection at multiplicities capable of largely overcoming antiretroviral inhibition. Compared with cell-free infection of T cells, VS-transmission by macrophages is equally susceptible to broadly neutralising antibodies (bNAbs) against gp120, but relatively resistant to bNAbs targeting the membrane-proximal external region of gp41, probably via steric hindrance. In a related project, I investigated how HIV-1-infected CD4+ T cells might infect macrophages. Interaction of macrophages with HIV-1-infected CD4+ T cells resulted in rapid phagocytic uptake of the infected T cells, which correlated with efficient productive macrophage infection. This route of transmission also permitted macrophage infection with transmitted/founder HIV-1 clones that inefficiently replicate in macrophages following cell-free inoculation, potentially implicating macrophages in the mucosal amplification of transmitted HIV-1. Overall, these data indicate an important role for cell-to-cell transmission between macrophages and CD4+ T cells in various aspects of HIV-1 pathogenesis.

Published
2013

11. A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273

Author

Lee, Ivan T., primary, Cosgrove, Catherine A., additional, Moore, Patrick, additional, Bethune, Claire, additional, Nally, Rhiannon, additional, Bula, Marcin, additional, Kalra, Philip A., additional, Clark, Rebecca, additional, Dargan, Paul I., additional, Boffito, Marta, additional, Sheridan, Ray, additional, Moran, Ed, additional, Darton, Thomas C., additional, Burns, Fiona, additional, Saralaya, Dinesh, additional, Duncan, Christopher J. A., additional, Lillie, Patrick, additional, Ramos, Alberto San Francisco, additional, Galiza, Eva, additional, Heath, Paul T., additional, Girard, Bethany, additional, Parker, Christy, additional, Rust, Dondi, additional, Mehta, Shraddha, additional, Windt, Elizabeth de, additional, Sutherland, Andrea, additional, Tomassini, Joanne E., additional, Dutko, Frank J., additional, Chalkias, Spyros, additional, Deng, Weiping, additional, Chen, Xing, additional, Tracy, LaRee, additional, Zhou, Honghong, additional, Miller, Jacqueline M., additional, and Das, Rituparna, additional

Published
2023
Full Text
View/download PDF

12. Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Author

Mentzer, Alexander J., O’connor, Daniel, Bibi, Sagida, Chelysheva, Irina, Clutterbuck, Elizabeth A., Demissie, Tesfaye, Dinesh, Tanya, Edwards, Nick J., Felle, Sally, Feng, Shuo, Flaxman, Amy L., Karp-tatham, Eleanor, Li, Grace, Liu, Xinxue, Marchevsky, Natalie, Godfrey, Leila, Makinson, Rebecca, Bull, Maireid B., Fowler, Jamie, Alamad, Bana, Malinauskas, Tomas, Chong, Amanda Y., Sanders, Katherine, Shaw, Robert H., Voysey, Merryn, Cavey, Ana, Minassian, Angela, Stuart, Arabella, Khozoee, Baktash, Hanumunthadu, Brama, Angus, Brian, Smith, Catherine C., Turnbull, Iain, Kwok, Jonathan, Emary, Katherine R. W., Cifuentes, Liliana, Ramasamy, Maheshi N., Cicconi, Paola, Finn, Adam, Mcgregor, Alastair C., Collins, Andrea M., Smith, Andrew, Goodman, Anna L., Green, Christopher A., Duncan, Christopher J. A., Williams, Christopher J. A., Ferreira, Daniela M., Turner, David P. J., Thomson, Emma C., Faust, Saul N., and Group, Oxford COVID Vaccine Trial Genetics Study Team

Subjects
General Medicine, General Biochemistry, Genetics and Molecular Biology
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between individuals, and immune responses correlate with vaccine efficacy. Using data from 1,076 participants enrolled in ChAdOx1 nCov-19 vaccine efficacy trials in the United Kingdom, we found that inter-individual variation in normalized antibody responses against SARS-CoV-2 spike and its receptor-binding domain (RBD) at 28 days after first vaccination shows genome-wide significant association with major histocompatibility complex (MHC) class II alleles. The most statistically significant association with higher levels of anti-RBD antibody was HLA-DQB1*06 (P = 3.2 × 10−9), which we replicated in 1,677 additional vaccinees. Individuals carrying HLA-DQB1*06 alleles were less likely to experience PCR-confirmed breakthrough infection during the ancestral SARS-CoV-2 virus and subsequent Alpha variant waves compared to non-carriers (hazard ratio = 0.63, 0.42–0.93, P = 0.02). We identified a distinct spike-derived peptide that is predicted to bind differentially to HLA-DQB1*06 compared to other similar alleles, and we found evidence of increased spike-specific memory B cell responses in HLA-DQB1*06 carriers at 84 days after first vaccination. Our results demonstrate association of HLA type with Coronavirus Disease 2019 (COVID-19) vaccine antibody response and risk of breakthrough infection, with implications for future vaccine design and implementation.

Published
2022

13. Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001

Author

Lazarus, Rajeka, Taucher, Christian, Brown, Claire, Corbic, Irena, Danon, Leon, Dubischar, Katrin, Duncan, Christopher J A, Eder-Lingelbach, Susanne, Faust, Saul N, Green, Christopher, Gokani, Karishma, Hochreiter, Romana, Wright, Johanna Kellett, Kwon, Dowan, Middleditch, Alexander, Munro, Alasdair P S, Naker, Kush, Penciu, Florentina, Price, David, Querton, Benedicte, Riaz, Tawassal, Ross-Russell, Amy, Sanchez-Gonzalez, Amada, Wardle, Hayley, Warren, Sarah, and Finn, Adam

Abstract

Objectives: We aimed to evaluate the safety and optimal dose of a novel inactivated whole-virus adjuvanted vaccine against SARS-CoV-2: VLA2001. Methods: We conducted an open-label, dose-escalation study followed by a double-blind randomized trial using low, medium and high doses of VLA2001 (1:1:1). The primary safety outcome was the frequency and severity of solicited local and systemic reactions within 7 days after vaccination. The primary immunogenicity outcome was the geometric mean titre (GMT) of neutralizing antibodies against SARS-CoV-2 two weeks after the second vaccination. The study is registered as NCT04671017. Results: Between December 16, 2020, and June 3, 2021, 153 healthy adults aged 18–55 years were recruited in the UK. Overall, 81.7% of the participants reported a solicited AE, with injection site tenderness (58.2%) and headache (46.4%) being the most frequent. Only 2 participants reported a severe solicited event. Up to day 106, 131 (85.6%) participants had reported any AE. All observed incidents were transient and non-life threatening in nature. Immunogenicity measured at 2 weeks after completion of the two-dose priming schedule, showed significantly higher GMTs of SARS-CoV-2 neutralizing antibody titres in the highest dose group (GMT 545.6; 95% CI: 428.1, 695.4) which were similar to a panel of convalescent sera (GMT 526.9; 95% CI: 336.5, 825.1). Seroconversion rates of neutralizing antibodies were also significantly higher in the high-dose group (>90%) compared to the other dose groups. In the high dose group, antigen-specific IFN-γ expressing T-cells reactive against the S, M and N proteins were observed in 76, 36 and 49%, respectively. Conclusions: VLA2001 was well tolerated in all tested dose groups, and no safety signal of concern was identified. The highest dose group showed statistically significantly stronger immunogenicity with similar tolerability and safety, and was selected for phase 3 clinical development.

Published
2022

14. Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia

Author

Hanrath, Aidan T., primary, Hatton, Catherine F., additional, Gothe, Florian, additional, Browne, Cathy, additional, Vowles, Jane, additional, Leary, Peter, additional, Cockell, Simon J., additional, Cowley, Sally A., additional, James, William S., additional, Hambleton, Sophie, additional, and Duncan, Christopher J. A., additional

Published
2022
Full Text
View/download PDF

16. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

Author

Ferrada, Marcela A., primary, Savic, Sinisa, additional, Cardona, Daniela Ospina, additional, Collins, Jason C., additional, Alessi, Hugh, additional, Gutierrez-Rodrigues, Fernanda, additional, Kumar, Dinesh Babu Uthaya, additional, Wilson, Lorena, additional, Goodspeed, Wendy, additional, Topilow, James S., additional, Paik, Julie J., additional, Poulter, James A., additional, Kermani, Tanaz A., additional, Koster, Matthew J., additional, Warrington, Kenneth J., additional, Cargo, Catherine, additional, Tattersall, Rachel S., additional, Duncan, Christopher J. A., additional, Cantor, Anna, additional, Hoffmann, Patrycja, additional, Payne, Elspeth M., additional, Bonnekoh, Hanna, additional, Krause, Karoline, additional, Cowen, Edward W., additional, Calvo, Katherine R., additional, Patel, Bhavisha A., additional, Ombrello, Amanda K., additional, Kastner, Daniel L., additional, Young, Neal S., additional, Werner, Achim, additional, Grayson, Peter C., additional, and Beck, David B., additional

Published
2022
Full Text
View/download PDF

17. Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Author

Shields, Adrian M., primary, Tadros, Susan, additional, Al-Hakim, Adam, additional, Nell, Jeremy M., additional, Lin, Me Me Nay, additional, Chan, Michele, additional, Goddard, Sarah, additional, Dempster, John, additional, Dziadzio, Magdalena, additional, Patel, Smita Y., additional, Elkalifa, Shuayb, additional, Huissoon, Aarnoud, additional, Duncan, Christopher J. A., additional, Herwadkar, Archana, additional, Khan, Sujoy, additional, Bethune, Claire, additional, Elcombe, Suzanne, additional, Thaventhiran, James, additional, Klenerman, Paul, additional, Lowe, David M., additional, Savic, Sinisa, additional, Burns, Siobhan O., additional, and Richter, Alex G., additional

Published
2022
Full Text
View/download PDF

18. mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals

Author

Longet, Stephanie, primary, Hargreaves, Alexander, additional, Healy, Saoirse, additional, Brown, Rebecca, additional, Hornsby, Hailey R., additional, Meardon, Naomi, additional, Tipton, Tom, additional, Barnes, Eleanor, additional, Dunachie, Susanna, additional, Duncan, Christopher J. A., additional, Klenerman, Paul, additional, Richter, Alex, additional, Turtle, Lance, additional, de Silva, Thushan I., additional, and Carroll, Miles W., additional

Published
2022
Full Text
View/download PDF

19. Single-cell multi-omics analysis of the immune response in COVID-19

Author

Stephenson, Emily, Reynolds, Gary, Botting, Rachel A., Calero-Nieto, Fernando J., Morgan, Michael D., Tuong, Zewen Kelvin, Bach, Karsten, Sungnak, Waradon, Worlock, Kaylee B., Yoshida, Masahiro, Kumasaka, Natsuhiko, Kania, Katarzyna, Engelbert, Justin, Olabi, Bayanne, Spegarova, Jarmila Stremenova, Wilson, Nicola K., Mende, Nicole, Jardine, Laura, Gardner, Louis C. S., Goh, Issac, Horsfall, Dave, McGrath, Jim, Webb, Simone, Mather, Michael W., Lindeboom, Rik G. H., Dann, Emma, Huang, Ni, Polanski, Krzysztof, Prigmore, Elena, Gothe, Florian, Scott, Jonathan, Payne, Rebecca P., Baker, Kenneth F., Hanrath, Aidan T., Schim van der Loeff, Ina C. D., Barr, Andrew S., Sanchez-Gonzalez, Amada, Bergamaschi, Laura, Mescia, Federica, Barnes, Josephine L., Kilich, Eliz, de Wilton, Angus, Saigal, Anita, Saleh, Aarash, Janes, Sam M., Smith, Claire M., Gopee, Nusayhah, Wilson, Caroline, Coupland, Paul, Coxhead, Jonathan M., Kiselev, Vladimir Yu, van Dongen, Stijn, Bacardit, Jaume, King, Hamish W., Rostron, Anthony J., Simpson, A. John, Hambleton, Sophie, Laurenti, Elisa, Lyons, Paul A., Meyer, Kerstin B., Nikolić, Marko Z., Duncan, Christopher J. A., Smith, Kenneth G. C., Teichmann, Sarah A., Clatworthy, Menna R., Marioni, John C., Göttgens, Berthold, and Haniffa, Muzlifah

Subjects
Proteome, COVID-19, Cross-Sectional Studies, Humans, Monocytes, Receptors, Antigen, B-Cell, Receptors, Antigen, T-Cell, SARS-CoV-2, Single-Cell Analysis, T-Lymphocytes, Transcriptome, CD34, Biology, Peripheral blood mononuclear cell, Article, General Biochemistry, Genetics and Molecular Biology, Immune system, Antigen, Receptors, Platelet activation, Progenitor cell, B-Cell, RNA sequencing, General Medicine, T-Cell, Haematopoiesis, Viral infection, Immunology, Infection, CD8
Abstract

Analysis of human blood immune cells provides insights into the coordinated response to viral infections such as severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). We performed single-cell transcriptome, surface proteome and T and B lymphocyte antigen receptor analyses of over 780,000 peripheral blood mononuclear cells from a cross-sectional cohort of 130 patients with varying severities of COVID-19. We identified expansion of nonclassical monocytes expressing complement transcripts (CD16+C1QA/B/C+) that sequester platelets and were predicted to replenish the alveolar macrophage pool in COVID-19. Early, uncommitted CD34+ hematopoietic stem/progenitor cells were primed toward megakaryopoiesis, accompanied by expanded megakaryocyte-committed progenitors and increased platelet activation. Clonally expanded CD8+ T cells and an increased ratio of CD8+ effector T cells to effector memory T cells characterized severe disease, while circulating follicular helper T cells accompanied mild disease. We observed a relative loss of IgA2 in symptomatic disease despite an overall expansion of plasmablasts and plasma cells. Our study highlights the coordinated immune response that contributes to COVID-19 pathogenesis and reveals discrete cellular components that can be targeted for therapy., Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated with disease severity.

Published
2021

20. Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection

Author

Douglas, Alexander D., Edwards, Nick J., Duncan, Christopher J. A., Thompson, Fiona M., Sheehy, Susanne H., O'Hara, Geraldine A., Anagnostou, Nicholas, Walther, Michael, Webster, Daniel P., Dunachie, Susanna J., Porter, David W., Andrews, Laura, Gilbert, Sarah C., Draper, Simon J., Hill, Adrian V. S., and Bejon, Philip

Published
2013
Full Text
View/download PDF

23. Preliminary Assessment of the Efficacy of a T-Cell-Based Influenza Vaccine, MVA-NP+M1, in Humans

Author

Lillie, Patrick J., Berthoud, Tamara K., Powell, Timothy J., Lambe, Teresa, Mullarkey, Caitlin, Spencer, Alexandra J., Hamill, Matthew, Peng, Yanchun, Blais, Marie-Eve, Duncan, Christopher J. A., Sheehy, Susanne H., Havelock, Tom, Faust, Saul N., Williams, Rob Lambkin, Gilbert, Anthony, Oxford, John, Dong, Tao, Hill, Adrian V. S., and Gilbert, Sarah C.

Published
2012
Full Text
View/download PDF

25. Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

Author

O'Hara, Geraldine A., Duncan, Christopher J. A., Ewer, Katie J., Collins, Katharine A., Elias, Sean C., Halstead, Fenella D., Goodman, Anna L., Edwards, Nick J., Reyes-Sandoval, Arturo, Bird, Prudence, Rowland, Rosalind, Sheehy, Susanne H., Poulton, Ian D., Hutchings, Claire, Todryk, Stephen, Andrews, Laura, Folgori, Antonella, Berrie, Eleanor, Moyle, Sarah, Nicosia, Alfredo, Colloca, Stefano, Cortese, Riccardo, Siani, Loredana, Lawrie, Alison M., Gilbert, Sarah C., and Hill, Adrian V. S.

Published
2012
Full Text
View/download PDF

28. Is safe and feasible

Author

Duncan, Christopher J A, McCallum, Andrew D, Jones, Michael E, and MacDonald, Rona

Published
2011

30. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

Author

Angyal, Adrienn, primary, Longet, Stephanie, additional, Moore, Shona C, additional, Payne, Rebecca P, additional, Harding, Adam, additional, Tipton, Tom, additional, Rongkard, Patpong, additional, Ali, Mohammad, additional, Hering, Luisa M, additional, Meardon, Naomi, additional, Austin, James, additional, Brown, Rebecca, additional, Skelly, Donal, additional, Gillson, Natalie, additional, Dobson, Sue L, additional, Cross, Andrew, additional, Sandhar, Gurjinder, additional, Kilby, Jonathan A, additional, Tyerman, Jessica K, additional, Nicols, Alexander R, additional, Spegarova, Jarmila S, additional, Mehta, Hema, additional, Hornsby, Hailey, additional, Whitham, Rachel, additional, Conlon, Christopher P, additional, Jeffery, Katie, additional, Goulder, Philip, additional, Frater, John, additional, Dold, Christina, additional, Pace, Matthew, additional, Ogbe, Ane, additional, Brown, Helen, additional, Ansari, M Azim, additional, Adland, Emily, additional, Brown, Anthony, additional, Chand, Meera, additional, Shields, Adrian, additional, Matthews, Philippa C, additional, Hopkins, Susan, additional, Hall, Victoria, additional, James, William, additional, Rowland-Jones, Sarah L, additional, Klenerman, Paul, additional, Dunachie, Susanna, additional, Richter, Alex, additional, Duncan, Christopher J A, additional, Barnes, Eleanor, additional, Carroll, Miles, additional, Turtle, Lance, additional, de Silva, Thushan I, additional, Watson, Adam, additional, Angyal, Adrienn, additional, Alhussni, Ahmed, additional, Nicols, Alexander, additional, Deeks, Alexandra, additional, Webb-Bridges, Alice, additional, Jämsén, Anni, additional, Chawla, Anu, additional, Duncan, Christopher, additional, Conlon, Christopher, additional, O'Donnell, Denise, additional, Weeks, Esme, additional, Abuelgasim, Hibatullah, additional, Xiao, Huiyuan, additional, Spegarova, Jarmila, additional, Holmes, Jennifer, additional, Haworth, Jenny, additional, Tyerman, Jessica, additional, Kilby, Jonathan, additional, Cutteridge, Joseph, additional, Lillie, Katy, additional, Romaniuk, Leigh, additional, Denly, Lucy, additional, Hering, Luisa, additional, Ansari, M. Azim, additional, Kasanyinga, Mwila, additional, Matthews, Philippa, additional, Payne, Rebecca, additional, Wilson, Robert, additional, Rowland-Jones, Sarah, additional, Thomas, Sarah, additional, Moore, Shona, additional, Gardiner, Siobhan, additional, Tucker, Stephanie, additional, Dobson, Sue, additional, Adlou, Syed, additional, de Silva, Thushan, additional, Lawrie, Allan, additional, Smith, Nikki, additional, Turton, Helena, additional, Zawia, Amira, additional, Bayley, Martin, additional, Fairman, Alex, additional, Harrington, Kate, additional, Kirk, Rosemary, additional, Marsh, Louise, additional, Watson, Lisa, additional, Wood, Steven, additional, Diffey, Benjamin, additional, Jones, Chris, additional, Lett, Lauren, additional, Platt, Gareth, additional, Subramaniam, Krishanthi, additional, Wootton, Daniel, additional, Payne, Brendan, additional, Hambleton, Sophie, additional, Kelly, Sinead, additional, Marston, Judith, additional, Poolan, Sonia, additional, Turner, Dianne, additional, Haniffa, Muzlifah, additional, Stephenson, Emily, additional, Adele, Sandra, additional, Akhter, Hossain Delowar, additional, Chinnakannan, Senthil, additional, de Lara, Catherine, additional, Donnison, Timothy, additional, Hackstein, Carl-Philipp, additional, Lee, Lian, additional, Lim, Nicholas, additional, Malone, Tom, additional, Phillips, Eloise, additional, Ramamurthy, Narayan, additional, Robinson, Nichola, additional, Sampson, Oliver, additional, Eyre, David, additional, Simmons, Beatrice, additional, Stafford, Lizzie, additional, Mentzer, Alexander, additional, Amini, Ali, additional, Arancibia-Cárcamo, Carolina, additional, Provine, Nicholas, additional, Travis, Simon, additional, Dimitriadis, Stavros, additional, Johnson, Sile, additional, Foulkes, Sarah, additional, Khawam, Jameel, additional, Wellington, Edgar, additional, Gilbert-Jaramillo, Javier, additional, Knight, Michael, additional, Dupont, Maeva, additional, Horner, Emily, additional, Thaventhiran, James, additional, and Chalk, Jeremy, additional

Published
2022
Full Text
View/download PDF

31. Conjunctival epithelial cells resist productive SARS-CoV-2 infection

Author

Jackson, Robert M, primary, Hatton, Catherine F, additional, Spegarova, Jarmila Stremenova, additional, Georgiou, Maria, additional, Collin, Joseph, additional, Stephenson, Emily, additional, Verdon, Bernard, additional, Haq, Iram J, additional, Hussain, Rafiqul, additional, Coxhead, Jonathan M, additional, Mudhar, Hardeep-Singh, additional, Wagner, Bart, additional, Hasoon, Megan, additional, Davey, Tracey, additional, Rooney, Paul, additional, Anjam Khan, C.M., additional, Ward, Chris, additional, Brodlie, Malcolm, additional, Haniffa, Muzlifah, additional, Hambleton, Sophie, additional, Armstrong, Lyle, additional, Figueiredo, Francisco, additional, Queen, Rachel, additional, Duncan, Christopher J A, additional, and Lako, Majlinda, additional

Published
2021
Full Text
View/download PDF

32. T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire

Author

Swanson, Phillip A., Padilla, Marcelino, Hoyland, Wesley, McGlinchey, Kelly, Fields, Paul A., Bibi, Sagida, Faust, Saul N., McDermott, Adrian B., Lambe, Teresa, Pollard, Andrew J., Durham, Nicholas M., Kelly, Elizabeth J., Adlou, Syed, Aley, Parvinder K., Angus, Brian, Anslow, Rachel, Baker, Philip, Bansal, Himanshu, Beveridge, Amy, Bridges-Webb, Alice, Ching, Steven, Cicconi, Paola, Clutterbuck, Elizabeth A., Collins, Andrea M., Darton, Thomas C., Demissie, Tesfaye, Dinesh, Tanya, Douglas, Alexander D., Duncan, Christopher J. A., Ewer, Katie J., Felle, Sally, Finn, Adam, Folegatti, Pedro M., Fuskova, Michelle, Gilbert, Sarah C., Goodman, Anna, Green, Christopher A., Harbolick, Elizabeth, Hart, Thomas C., Hayes, Susana, Hill, Adrian V. S., Jenkin, Daniel, Jepson, Brett M., Kasanyinga, Mwila, Kerridge, Simon, Libri, Vincenzo, Lillie, Patrick J., McGregor, Alastair C., Minassian, Angela M., Mujadidi, Yama F., Pilataxi, Fernanda, Plested, Emma, Provstgaard-Morys, Samuel, Ramasamy, Maheshi, Robinson, Hannah, Sanders, Katherine, Smith, Andrew, Snape, Matthew D., Song, Rinn, Sutherland, Rebecca K., Thomson, Emma C., Toshner, Mark, Turner, David P. J., Voysey, Merryn, and Williams, Christopher J.

Subjects
COVID-19 Vaccines, SARS-CoV-2, Immunogenicity, T cell, Vaccination, T-cell receptor, Receptors, Antigen, T-Cell, COVID-19, Biology, Peripheral blood mononuclear cell, Article, T cell mediated immunity, medicine.anatomical_structure, ChAdOx1 nCoV-19, Spike Glycoprotein, Coronavirus, Immunology, medicine, Humans, Receptor, CD8
Abstract

AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+ and CD8+ T-cell responses induced by AZD1222 vaccination in peripheral blood mononuclear cells (PBMCs) from 280 unique vaccine recipients aged 18–85 years who enrolled in the phase 2/3 COV002 trial. Total spike-specific CD4+ T cell helper type 1 (Th1) and CD8+ T-cell responses were significantly increased in AZD1222-vaccinated adults of all ages following two doses of AZD1222. CD4+ Th2 responses following AZD1222 vaccination were not detected. Furthermore, AZD1222-specific Th1 and CD8+ T cells both displayed a high degree of polyfunctionality in all adult age groups. T-cell receptor (TCR) β sequences from vaccinated participants mapped against TCR sequences known to react to SARS-CoV-2 revealed substantial breadth and depth across the SARS-CoV-2 spike protein for the AZD1222-induced CD4+ and CD8+ T-cell responses. Overall, AZD1222 vaccination induced a robust, polyfunctional Th1-dominated T-cell response, with broad CD4+ and CD8+ T-cell coverage across the SARS-CoV-2 spike protein.One Sentence SummaryPolyfunctional CD4+ and CD8+ T-cell responses are elicited against the SARS-CoV-2 spike protein following vaccination with AZD1222

Published
2021

33. Persistent SARS-CoV-2 Infection in Patients With Secondary Antibody Deficiency: Successful Clearance Following Combination Casirivimab and Imdevimab (REGN-COV2) Monoclonal Antibody Therapy

Author

Taha, Yusri, primary, Wardle, Hayley, additional, Evans, Adam B., additional, Hunter, Ewan R., additional, Marr, Helen, additional, Osborne, Wendy, additional, Bashton, Matthew, additional, Smith, Darren, additional, Burton-Fanning, Shirelle, additional, Schmid, Matthias L., additional, and Duncan, Christopher J A, additional

Published
2021
Full Text
View/download PDF

34. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Author

Voysey, Merryn, Clemens, Sue Ann Costa, Madhi, Shabir A., Weckx, Lily Y., Folegatti, Pedro M., Aley, Parvinder K., Angus, Brian, Baillie, Vicky L., Barnabas, Shaun L., Bhorat, Qasim E., Bibi, Sagida, Briner, Carmen, Cicconi, Paola, Collins, Andrea M., Colin-Jones, Rachel, Cutland, Clare L., Darton, Thomas C., Dheda, Keertan, Duncan, Christopher J. A., Emary, Katherine R. W., Ewer, Katie J., Fairlie, Lee, Faust, Saul N., Feng, Shuo, Ferreira, Daniela M., Finn, Adam, Goodman, Anna L., Green, Catherine M., Green, Christopher A., Heath, Paul T., Hill, Catherine, Hill, Helen, Hirsch, Ian, Hodgson, Susanne H. C., Izu, Alane, Jackson, Susan, Jenkin, Daniel, Joe, Carina C. D., Kerridge, Simon, Koen, Anthonet, Kwatra, Gaurav, Lazarus, Rajeka, Lawrie, Alison M., Lelliott, Alice, Libri, Vincenzo, Lillie, Patrick J., Mallory, Raburn, Mendes, Ana V. A., Milan, Eveline P., Minassian, Angela M., McGregor, Alastair, Morrison, Hazel, Mujadidi, Yama F., Nana, Anusha, O'Reilly, Peter J., Padayachee, Sherman D., Pittella, Ana, Plested, Emma, Pollock, Katrina M., Ramasamy, Maheshi N., Rhead, Sarah, Schwarzbold, Alexandre V., Singh, Nisha, Smith, Andrew, Song, Rinn, Snape, Matthew D., Sprinz, Eduardo, Sutherland, Rebecca K., Tarrant, Richard, Thomson, Emma C., Török, Mark and Turner, Sorio, Guilherme L., Sorley, Kim, Sosa-Rodriguez, Tiffany, Souza, Cinthia M.C.D.L., Souza, Bruno S.D.F., Souza, Alessandra R., Spencer, Alexandra J., Spina, Fernanda, Spoors, Louise, Stafford, Lizzie, Stamford, Imogen, Starinskij, Igor, Stein, Ricardo, Steven, Jill, Stockdale, Lisa, Stockwell, Lisa V., Strickland, Louise H., Stuart, Arabella C., Sturdy, Ann, Sutton, Natalina, Szigeti, Anna, Tahiri-Alaoui, Abdessamad, Tanner, Rachel, Taoushanis, Carol, Tarr, Alexander W., Taylor, Keja, Taylor, Ursula, Taylor, Iona Jennifer, Taylor, Justin, te Water Naude, Rebecca, Themistocleous, Yrene, Themistocleous, Andreas, Thomas, Merin, Thomas, Kelly, Thomas, Tonia M., Thombrayil, Asha, Thompson, Fawziyah, Thompson, Amber, Thompson, Kevin, Thompson, Ameeka, Thomson, Julia, Thornton-Jones, Viv, Tighe, Patrick J., Tinoco, Lygia Accioly, Tiongson, Gerlynn, Tladinyane, Bonolo, Tomasicchio, Michele, Tomic, Adriana, Tonks, Susan, Tran, Nguyen, Tree, Julia, Trillana, Gerry, Trinham, Charlotte, Trivett, Rose, Truby, Adam, Tsheko, Betty Lebogang, Turabi, Aadil, Turner, Richard, Turner, Cheryl, Ulaszewska, Marta, Underwood, Benjamin R., Varughese, Rachel, Verbart, Dennis, Verheul, Marije, Vichos, Iason, Vieira, Taiane, Waddington, Claire S., Walker, Laura, Wallis, Erica, Wand, Matthew, Warbick, Deborah, Wardell, Theresa, Warimwe, George, Warren, Sarah C., Watkins, Bridget, Watson, Ekaterina, Webb, Stewart, Webb-Bridges, Alice, Webster, Angela, Welch, Jessica, Wells, Jeanette, West, Alison, White, Caroline, White, Rachel, Williams, Paul, Williams, Rachel L., Winslow, Rebecca, Woodyer, Mark, Worth, Andrew T., Wright, Danny, Wroblewska, Marzena, Yao, Andy, Zimmer, Rafael, Zizi, Dalila, and Zuidewind, Peter

Abstract

Background: \ud A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials.\ud \ud Methods: \ud This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674.\ud \ud Findings: \ud Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation.\ud \ud Interpretation: \ud ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.\ud \ud Funding: \ud UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D’Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca.

Published
2021

35. Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19

Author

Stamatelopoulos, Kimon Georgiopoulos, Georgios Baker, Kenneth F. and Tiseo, Giusy Delialis, Dimitrios Lazaridis, Charalampos and Barbieri, Greta Masi, Stefano Vlachogiannis, I, Nikolaos and Sopova, Kateryna Mengozzi, Alessandro Ghiadoni, Lorenzo van der Loeff, Ina Schim Hanrath, Aidan T. Ajdini, Bajram and Vlachopoulos, Charalambos Dimopoulos, Meletios A. Duncan, Christopher J. A. Falcone, Marco Stellos, Konstantinos Pisa COVID-19 Res Grp Newcastle COVID-19 Res Grp

Abstract

Accurate risk stratification in COVID-19 patients consists a major clinical need to guide therapeutic strategies. We sought to evaluate the prognostic role of estimated pulse wave velocity (ePWV), a marker of arterial stiffness which reflects overall arterial integrity and aging, in risk stratification of hospitalized patients with COVID-19. This retrospective, longitudinal cohort study, analyzed a total population of 1671 subjects consisting of 737 hospitalized COVID-19 patients consecutively recruited from two tertiary centers (Newcastle cohort: n = 471 and Pisa cohort: n = 266) and a non-COVID control cohort (n = 934). Arterial stiffness was calculated using validated formulae for ePWV. ePWV progressively increased across the control group, COVID-19 survivors and deceased patients (adjusted mean increase per group 1.89 m/s, P < 0.001). Using a machine learning approach, ePWV provided incremental prognostic value and improved reclassification for mortality over the core model including age, sex and comorbidities [AUC (core model + ePWV vs. core model) = 0.864 vs. 0.755]. ePWV provided similar prognostic value when pulse pressure or hs-Troponin were added to the core model or over its components including age and mean blood pressure (p < 0.05 for all). The optimal prognostic ePWV value was 13.0 m/s. ePWV conferred additive discrimination (AUC: 0.817 versus 0.779, P < 0.001) and reclassification value (NRI = 0.381, P < 0.001) over the 4C Mortality score, a validated score for predicting mortality in COVID-19 and the Charlson comorbidity index. We suggest that calculation of ePWV, a readily applicable estimation of arterial stiffness, may serve as an additional clinical tool to refine risk stratification of hospitalized patients with COVID-19 beyond established risk factors and scores.

Published
2021

39. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Author

Emary, Katherine R W, primary, Golubchik, Tanya, additional, Aley, Parvinder K, additional, Ariani, Cristina V, additional, Angus, Brian, additional, Bibi, Sagida, additional, Blane, Beth, additional, Bonsall, David, additional, Cicconi, Paola, additional, Charlton, Sue, additional, Clutterbuck, Elizabeth A, additional, Collins, Andrea M, additional, Cox, Tony, additional, Darton, Thomas C, additional, Dold, Christina, additional, Douglas, Alexander D, additional, Duncan, Christopher J A, additional, Ewer, Katie J, additional, Flaxman, Amy L, additional, Faust, Saul N, additional, Ferreira, Daniela M, additional, Feng, Shuo, additional, Finn, Adam, additional, Folegatti, Pedro M, additional, Fuskova, Michelle, additional, Galiza, Eva, additional, Goodman, Anna L, additional, Green, Catherine M, additional, Green, Christopher A, additional, Greenland, Melanie, additional, Hallis, Bassam, additional, Heath, Paul T, additional, Hay, Jodie, additional, Hill, Helen C, additional, Jenkin, Daniel, additional, Kerridge, Simon, additional, Lazarus, Rajeka, additional, Libri, Vincenzo, additional, Lillie, Patrick J, additional, Ludden, Catherine, additional, Marchevsky, Natalie G, additional, Minassian, Angela M, additional, McGregor, Alastair C, additional, Mujadidi, Yama F, additional, Phillips, Daniel J, additional, Plested, Emma, additional, Pollock, Katrina M, additional, Robinson, Hannah, additional, Smith, Andrew, additional, Song, Rinn, additional, Snape, Matthew D, additional, Sutherland, Rebecca K, additional, Thomson, Emma C, additional, Toshner, Mark, additional, Turner, David P J, additional, Vekemans, Johan, additional, Villafana, Tonya L, additional, Williams, Christopher J, additional, Hill, Adrian V S, additional, Lambe, Teresa, additional, Gilbert, Sarah C, additional, Voysey, Merryn, additional, Ramasamy, Maheshi N, additional, and Pollard, Andrew J, additional

Published
2021
Full Text
View/download PDF

40. SARS-CoV-2 Testing of 11,884 Healthcare Workers at an Acute NHS Hospital Trust in England: A Retrospective Analysis

Author

Hanrath, Aidan T., primary, Schim van der Loeff, Ina, additional, Lendrem, Dennis W., additional, Baker, Kenneth F., additional, Price, David A., additional, McDowall, Peter, additional, McDowall, Kiera, additional, Cook, Susan, additional, Towns, Peter, additional, Schwab, Ulrich, additional, Evans, Adam, additional, Dixon, Jill, additional, Collins, Jennifer, additional, Burton-Fanning, Shirelle, additional, Saunders, David, additional, Harwood, Jayne, additional, Samuel, Julie, additional, Schmid, Matthias L., additional, Pareja-Cebrian, Lucia, additional, Hunter, Ewan, additional, Murphy, Elizabeth, additional, Taha, Yusri, additional, Payne, Brendan A. I., additional, and Duncan, Christopher J. A., additional

Published
2021
Full Text
View/download PDF

41. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Author

Voysey, Merryn, primary, Costa Clemens, Sue Ann, additional, Madhi, Shabir A, additional, Weckx, Lily Y, additional, Folegatti, Pedro M, additional, Aley, Parvinder K, additional, Angus, Brian, additional, Baillie, Vicky L, additional, Barnabas, Shaun L, additional, Bhorat, Qasim E, additional, Bibi, Sagida, additional, Briner, Carmen, additional, Cicconi, Paola, additional, Clutterbuck, Elizabeth A, additional, Collins, Andrea M, additional, Cutland, Clare L, additional, Darton, Thomas C, additional, Dheda, Keertan, additional, Dold, Christina, additional, Duncan, Christopher J A, additional, Emary, Katherine R W, additional, Ewer, Katie J, additional, Flaxman, Amy, additional, Fairlie, Lee, additional, Faust, Saul N, additional, Feng, Shuo, additional, Ferreira, Daniela M, additional, Finn, Adam, additional, Galiza, Eva, additional, Goodman, Anna L, additional, Green, Catherine M, additional, Green, Christopher A, additional, Greenland, Melanie, additional, Hill, Catherine, additional, Hill, Helen C, additional, Hirsch, Ian, additional, Izu, Alane, additional, Jenkin, Daniel, additional, Joe, Carina C D, additional, Kerridge, Simon, additional, Koen, Anthonet, additional, Kwatra, Gaurav, additional, Lazarus, Rajeka, additional, Libri, Vincenzo, additional, Lillie, Patrick J, additional, Marchevsky, Natalie G, additional, Marshall, Richard P, additional, Mendes, Ana V A, additional, Milan, Eveline P, additional, Minassian, Angela M, additional, McGregor, Alastair, additional, Mujadidi, Yama F, additional, Nana, Anusha, additional, Padayachee, Sherman D, additional, Phillips, Daniel J, additional, Pittella, Ana, additional, Plested, Emma, additional, Pollock, Katrina M, additional, Ramasamy, Maheshi N, additional, Ritchie, Adam J, additional, Robinson, Hannah, additional, Schwarzbold, Alexandre V, additional, Smith, Andrew, additional, Song, Rinn, additional, Snape, Matthew D, additional, Sprinz, Eduardo, additional, Sutherland, Rebecca K, additional, Thomson, Emma C, additional, Török, M Estée, additional, Toshner, Mark, additional, Turner, David P J, additional, Vekemans, Johan, additional, Villafana, Tonya L, additional, White, Thomas, additional, Williams, Christopher J, additional, Douglas, Alexander D, additional, Hill, Adrian V S, additional, Lambe, Teresa, additional, Gilbert, Sarah C, additional, Pollard, Andrew J, additional, Aban, Marites, additional, Abeyskera, Kushala W.M., additional, Aboagye, Jeremy, additional, Adam, Matthew, additional, Adams, Kirsty, additional, Adamson, James P., additional, Adewatan, Gbadebo, additional, Adlou, Syed, additional, Ahmed, Khatija, additional, Akhalwaya, Yasmeen, additional, Akhalwaya, Saajida, additional, Alcock, Andrew, additional, Ali, Aabidah, additional, Allen, Elizabeth R., additional, Allen, Lauren, additional, Alvernaz, Felipe B., additional, Amorim, Fabio Santos, additional, Andrade, Claudia Sala, additional, Andritsou, Foteini, additional, Anslow, Rachel, additional, Arbe-Barnes, Edward H., additional, Ariaans, Mark P., additional, Arns, Beatriz, additional, Arruda, Laiana, additional, Assad, Luiza, additional, Azi, Paula De Almeida, additional, Azi, Lorena De Almeida, additional, Babbage, Gavin, additional, Bailey, Catherine, additional, Baker, Kenneth F., additional, Baker, Megan, additional, Baker, Natalie, additional, Baker, Philip, additional, Baleanu, Ioana, additional, Bandeira, Danieli, additional, Bara, Anna, additional, Barbosa, Marcella A.S., additional, Barker, Debbie, additional, Barlow, Gavin D., additional, Barnes, Eleanor, additional, Barr, Andrew S., additional, Barrett, Jordan R., additional, Barrett, Jessica, additional, Barrett, Kelly, additional, Bates, Louise, additional, Batten, Alexander, additional, Beadon, Kirsten, additional, Beales, Emily, additional, Beckley, Rebecca, additional, Belij-Rammerstorfer, Sandra, additional, Bell, Jonathan, additional, Bellamy, Duncan, additional, Belton, Sue, additional, Berg, Adam, additional, Bermejo, Laura, additional, Berrie, Eleanor, additional, Berry, Lisa, additional, Berzenyi, Daniella, additional, Beveridge, Amy, additional, Bewley, Kevin R., additional, Bharaj, Inderjeet, additional, Bhikha, Sutika, additional, Bhorat, Asad E., additional, Bhorat, Zaheda E., additional, Bijker, Else Margreet, additional, Birch, Sarah, additional, Birch, Gurpreet, additional, Birchall, Kathryn, additional, Bird, Adam, additional, Bird, Olivia, additional, Bisnauthsing, Karen, additional, Bittaye, Mustapha, additional, Blackwell, Luke, additional, Blacow, Rachel, additional, Bletchly, Heather, additional, Blundell, Caitlin L., additional, Blundell, Susannah R., additional, Bodalia, Pritesh, additional, Bolam, Emma, additional, Boland, Elena, additional, Bormans, Daan, additional, Borthwick, Nicola, additional, Bowring, Francesca, additional, Boyd, Amy, additional, Bradley, Penny, additional, Brenner, Tanja, additional, Bridges-Webb, Alice, additional, Brown, Phillip, additional, Brown, Claire, additional, Brown-O'Sullivan, Charlie, additional, Bruce, Scott, additional, Brunt, Emily, additional, Budd, William, additional, Bulbulia, Yusuf A., additional, Bull, Melanie, additional, Burbage, Jamie, additional, Burn, Aileen, additional, Buttigieg, Karen R., additional, Byard, Nicholas, additional, Cabrera Puig, Ingrid, additional, Calvert, Anna, additional, Camara, Susana, additional, Cao, Michelangelo, additional, Cappuccini, Federica, additional, Cardona, Rita, additional, Cardoso, João R., additional, Carr, Melanie, additional, Carroll, Miles W., additional, Carson-Stevens, Andrew, additional, Carvalho, Yasmin de M., additional, Casey, Helen R., additional, Cashen, Paul, additional, Castro, Thais R.Y., additional, Castro, Lucia Carratala, additional, Cathie, Katrina, additional, Cavey, Ana, additional, Cerbino-Neto, José, additional, Cezar, Luiz Fernando F., additional, Chadwick, Jim, additional, Chanice, Chanice, additional, Chapman, David, additional, Charlton, Sue, additional, Cheliotis, Katerina S., additional, Chelysheva, Irina, additional, Chester, Oliver, additional, Chiplin, Emily, additional, Chita, Sunder, additional, Cho, Jee-Sun, additional, Cifuentes, Liliana, additional, Clark, Elizabeth, additional, Clark, Matthew, additional, Colin-Jones, Rachel, additional, Collins, Sarah L.K., additional, Colton, Hayley, additional, Conlon, Christopher P., additional, Connarty, Sean, additional, Coombes, Naomi, additional, Cooper, Cushla, additional, Cooper, Rachel, additional, Cornelissen, Lynne, additional, Corrah, Tumena, additional, Cosgrove, Catherine A., additional, Costa, Fernanda Barroso, additional, Cox, Tony, additional, Crocker, Wendy E.M., additional, Crosbie, Sarah, additional, Cullen, Dan, additional, Cunha, Debora R.M.F., additional, Cunningham, Christina J., additional, Cuthbertson, Fiona C., additional, da Costa, Daniel Marinho, additional, Da Guarda, Suzete N. Farias, additional, da Silva, Larissa P., additional, da Silva Moraes, Antonio Carlos, additional, Damratoski, Brad E., additional, Danos, Zsofia, additional, Dantas, Maria T.D.C., additional, Datoo, Mehreen S., additional, Datta, Chandrabali, additional, Davids, Malika, additional, Davies, Sarah L., additional, Davies, Kelly, additional, Davies, Hannah, additional, Davies, Sophie, additional, Davies, Judith, additional, Davis, Elizabeth J., additional, Davis, John, additional, de Carvalho, José A.M., additional, De Jager, Jeanne, additional, de Jesus Jnr, Sergio, additional, De Oliveira Kalid, Lis Moreno, additional, Dearlove, David, additional, Demissie, Tesfaye, additional, Desai, Amisha, additional, Di Marco, Stefania, additional, Di Maso, Claudio, additional, Dinesh, Tanya, additional, Docksey, Claire, additional, Dong, Tao, additional, Donnellan, Francesca R., additional, Dos Santos, Tannyth Gomes, additional, Dos Santos, Thainá G., additional, Dos Santos, Erika Pachecho, additional, Douglas, Naomi, additional, Downing, Charlotte, additional, Drake, Jonathan, additional, Drake-Brockman, Rachael, additional, Drury, Ruth, additional, Du Plessis, Joan, additional, Dunachie, Susanna J., additional, Duncan, Andrew, additional, Easom, Nicholas J.W., additional, Edwards, Mandy, additional, Edwards, Nick J., additional, Edwards, Frances, additional, El Muhanna, Omar M., additional, Elias, Sean C., additional, Ellison-Handley, Branwen, additional, Elmore, Michael J., additional, English, Marcus Rex, additional, Esmail, Alisgair, additional, Essack, Yakub Moosa, additional, Farooq, Mutjaba, additional, Fedosyuk, Sofiya, additional, Felle, Sally, additional, Ferguson, Susie, additional, Ferreira Da Silva, Carla, additional, Field, Samantha, additional, Fisher, Richard, additional, Fletcher, James, additional, Fofie, Hazel, additional, Fok, Henry, additional, Ford, Karen J., additional, Fothergill, Ross, additional, Fowler, Jamie, additional, Fraiman, Pedro H.A., additional, Francis, Emma, additional, Franco, Marilia M., additional, Frater, John, additional, Freire, Marilúcia S.M., additional, Fry, Samantha H., additional, Fudge, Sabrina, additional, Furlan Filho, Renato, additional, Furze, Julie, additional, Fuskova, Michelle, additional, Galian-Rubio, Pablo, additional, Garlant, Harriet, additional, Gavrila, Madita, additional, Gibbons, Karyna A., additional, Gilbride, Ciaran, additional, Gill, Hardeep, additional, Godwin, Kerry, additional, Gokani, Karishma, additional, Gonçalves, Maria Luisa Freire, additional, Gonzalez, Isabela G.S., additional, Goodall, Jack, additional, Goodwin, Jayne, additional, Goondiwala, Amina, additional, Gordon-Quayle, Katherine, additional, Gorini, Giacomo, additional, Goyanna, Alvaro, additional, Grab, Janet, additional, Gracie, Lara, additional, Green, Justin, additional, Greenwood, Nicola, additional, Greffrath, Johann, additional, Groenewald, Marisa M., additional, Gunawardene, Anishka, additional, Gupta, Gaurav, additional, Hackett, Mark, additional, Hallis, Bassam, additional, Hamaluba, Mainga, additional, Hamilton, Elizabeth, additional, Hamlyn, Joseph, additional, Hammersley, Daniel, additional, Hanrath, Aidan T., additional, Hanumunthadu, Brama, additional, Harris, Stephanie A., additional, Harris, Clair, additional, Harrison, Thomas D., additional, Harrison, Daisy, additional, Harris-Wright, Tara A., additional, Hart, Thomas C., additional, Hartnell, Birgit, additional, Haughney, John, additional, Hawkins, Sophia, additional, Hayano, Laís Y.M., additional, Head, Ian, additional, Heath, Paul T., additional, Henry, John Aaron, additional, Hermosin Herrera, Macarena, additional, Hettle, David B., additional, Higa, Cristhiane, additional, Hill, Jennifer, additional, Hodges, Gina, additional, Hodgson, Susanne, additional, Horne, Elizea, additional, Hou, Mimi M., additional, Houlihan, Catherine F., additional, Howe, Elizabeth, additional, Howell, Nicola, additional, Humphreys, Jonathan, additional, Humphries, Holly E., additional, Hurley, Katrina, additional, Huson, Claire, additional, Hyams, Catherine, additional, Hyder-Wright, Angela, additional, Ikram, Sabina, additional, Ishwarbhai, Alka, additional, Iveson, Poppy, additional, Iyer, Vidyashankara, additional, Jackson, Frederic, additional, Jackson, Susan, additional, Jaumdally, Shameem, additional, Jeffers, Helen, additional, Jesudason, Natasha, additional, Jones, Carina, additional, Jones, Christopher, additional, Jones, Kathryn, additional, Jones, Elizabeth, additional, Jorge, Marianna Rocha, additional, Joshi, Amar, additional, Júnior, Eduardo A.M.S., additional, Kailath, Reshma, additional, Kana, Faeeza, additional, Kar, Arnab, additional, Karampatsas, Konstantinos, additional, Kasanyinga, Mwila, additional, Kay, Linda, additional, Keen, Jade, additional, Kellett Wright, Johanna, additional, Kelly, Elizabeth J., additional, Kelly, Debbie, additional, Kelly, Dearbhla M., additional, Kelly, Sarah, additional, Kerr, David, additional, Khan, Liaquat, additional, Khozoee, Baktash, additional, Khurana, Ankush, additional, Kidd, Sarah, additional, Killen, Annabel, additional, Kinch, Jasmin, additional, Kinch, Patrick, additional, King, Lloyd D.W., additional, King, Thomas B., additional, Kingham, Lucy, additional, Klenerman, Paul, additional, Kluczna, Diana M., additional, Knapper, Francesca, additional, Knight, Julian C., additional, Knott, Daniel, additional, Koleva, Stanislava, additional, Lages, Pedro M., additional, Lang, Matilda, additional, Lang, Gail, additional, Larkworthy, Colin W., additional, Larwood, Jessica P.J., additional, Law, Rebecca, additional, Lawrie, Alison M., additional, Lazarus, Erica M., additional, Leach, Amanda, additional, Lees, Emily A., additional, Lelliott, Alice, additional, Lemm, Nana-Marie, additional, Lessa, Alvaro Edson Ramos, additional, Leung, Stephanie, additional, Li, Yuanyuan, additional, Lias, Amelia M., additional, Liatsikos, Konstantinos, additional, Linder, Aline, additional, Lipworth, Samuel, additional, Liu, Shuchang, additional, Liu, Xinxue, additional, Lloyd, Adam, additional, Lloyd, Stephanie, additional, Loew, Lisa, additional, Lopez Ramon, Raquel, additional, Lora, Leandro Bonecker, additional, Luz, Kleber Giovanni, additional, MacDonald, Jonathan C., additional, MacGregor, Gordon, additional, Madhavan, Meera, additional, Mainwaring, David O., additional, Makambwa, Edson, additional, Makinson, Rebecca, additional, Malahleha, Mookho, additional, Malamatsho, Ross, additional, Mallett, Garry, additional, Manning, Nicola, additional, Mansatta, Kushal, additional, Maoko, Takalani, additional, Marinou, Spyridoula, additional, Marlow, Emma, additional, Marques, Gabriela N., additional, Marriott, Paula, additional, Marshall, Richard P., additional, Marshall, Julia L., additional, Masenya, Masebole, additional, Masilela, Mduduzi, additional, Masters, Shauna K., additional, Mathew, Moncy, additional, Matlebjane, Hosea, additional, Matshidiso, Kedidimetse, additional, Mazur, Olga, additional, Mazzella, Andrea, additional, McCaughan, Hugh, additional, McEwan, Joanne, additional, McGlashan, Joanna, additional, McInroy, Lorna, additional, McRobert, Nicky, additional, McSwiggan, Steve, additional, Megson, Clare, additional, Mehdipour, Savviz, additional, Meijs, Wilma, additional, Mendonça, Renata N.Õ., additional, Mentzer, Alexander J., additional, Mesquita, Ana Carolina F., additional, Miralhes, Patricia, additional, Mirtorabi, Neginsadat, additional, Mitton, Celia, additional, Mnyakeni, Sibusiso, additional, Moghaddas, Fiona, additional, Molapo, Kgaogelo, additional, Moloi, Mapule, additional, Moore, Maria, additional, Moran, Marni, additional, Morey, Ella, additional, Morgans, Róisín, additional, Morris, Susan J., additional, Morris, Sheila, additional, Morrison, Hazel, additional, Morselli, Franca, additional, Morshead, Gertraud, additional, Morter, Richard, additional, Mottay, Lynelle, additional, Moultrie, Andrew, additional, Moyo, Nathifa, additional, Mpelembue, Mushiya, additional, Msomi, Sibekezelo, additional, Mugodi, Yvonne, additional, Mukhopadhyay, Ekta, additional, Muller, Jilly, additional, Munro, Alasdair, additional, Murphy, Sarah, additional, Mweu, Philomena, additional, Myerscough, Christopher, additional, Naik, Gurudutt, additional, Naker, Kush, additional, Nastouli, Eleni, additional, Ndlovu, Bongani, additional, Nikolaou, Elissavet, additional, Njenga, Cecilia, additional, Noal, Helena C., additional, Noé, Andrés, additional, Novaes, Gabrielle, additional, Nugent, Fay L., additional, Nunes, Géssika Lanzillo A., additional, O'Brien, Katie, additional, O'Connor, Daniel, additional, Oelofse, Suzette, additional, Oguti, Blanche, additional, Olchawski, Victoria, additional, Oldfield, Neil J., additional, Oliveira, Marianne G., additional, Oliveira, Catarina, additional, Oliveira, Isabelle Silva Queiroz, additional, Oommen-Jose, Aylin, additional, Oosthuizen, Angela, additional, O'Reilly, Paula, additional, O'Reilly, Peter J., additional, Osborne, Piper, additional, Owen, David R.J., additional, Owen, Lydia, additional, Owens, Daniel, additional, Owino, Nelly, additional, Pacurar, Mihaela, additional, Paiva, Brenda V.B., additional, Palhares, Edna M.F., additional, Palmer, Susan, additional, Parracho, Helena M. R.T., additional, Parsons, Karen, additional, Patel, Dipak, additional, Patel, Bhumika, additional, Patel, Faeezah, additional, Patrick-Smith, Maia, additional, Payne, Ruth O., additional, Peng, Yanchun, additional, Penn, Elizabeth J., additional, Pennington, Anna, additional, Peralta Alvarez, Marco Polo, additional, Pereira Stuchi, Bruno Pereira, additional, Perez, Ana Luiza, additional, Perinpanathan, Tanaraj, additional, Perring, James, additional, Perumal, Rubeshan, additional, Petkar, Sahir Yusuf, additional, Philip, Tricia, additional, Phillips, Jennifer, additional, Phohu, Mary Kgomotso, additional, Pickup, Lorinda, additional, Pieterse, Sonja, additional, Pinheiro, Jessica Morgana, additional, Piper, Jo, additional, Pipini, Dimitra, additional, Plank, Mary, additional, Plant, Sinéad, additional, Pollard, Samuel, additional, Pooley, Jennifer, additional, Pooran, Anil, additional, Poulton, Ian, additional, Powers, Claire, additional, Presa, Fernando B., additional, Price, David A., additional, Price, Vivien, additional, Primeira, Marcelo R., additional, Proud, Pamela C., additional, Provstgaard-Morys, Samuel, additional, Pueschel, Sophie, additional, Pulido, David, additional, Quaid, Sheena, additional, Rabara, Ria, additional, Radia, Kajal, additional, Rajapaska, Durga, additional, Rajeswaran, Thurkka, additional, Ramos, Leonardo, additional, Ramos, Alberto San Francisco, additional, Ramos Lopez, Fernando, additional, Rampling, Tommy, additional, Rand, Jade, additional, Ratcliffe, Helen, additional, Rawlinson, Tom, additional, Rea, David, additional, Rees, Byron, additional, Resuello-Dauti, Mila, additional, Reyes Pabon, Emilia, additional, Rhead, Sarah, additional, Riaz, Tawassal, additional, Ricamara, Marivic, additional, Richards, Alexander, additional, Richter, Alex, additional, Ritchie, Neil, additional, Ritchie, Adam J., additional, Robbins, Alexander J., additional, Roberts, Hannah, additional, Robinson, Ryan E., additional, Roche, Sophie, additional, Rollier, Christine, additional, Rose, Louisa, additional, Ross Russell, Amy L., additional, Rossouw, Lindie, additional, Royal, Simon, additional, Rudiansyah, Indra, additional, Ryalls, Kim, additional, Sabine, Charlotte, additional, Saich, Stephen, additional, Sale, Jessica C., additional, Salman, Ahmed M., additional, Salvador, Natalia, additional, Salvador, Stephannie, additional, Sampaio, Milla Dias, additional, Samson, Annette D., additional, Sanchez-Gonzalez, Amada, additional, Sanders, Helen, additional, Sanders, Katherine, additional, Santos, Erika, additional, Santos Guerra, Mayara F.S., additional, Satti, Iman, additional, Saunders, Jack E., additional, Saunders, Caroline, additional, Sayed, Aakifah Bibi Arif, additional, Schim van der Loeff, Ina, additional, Schmid, Annina B., additional, Schofield, Ella, additional, Screaton, Gavin R., additional, Seddiqi, Samiullah, additional, Segireddy, Rameswara R., additional, Senger, Roberta, additional, Serrano, Sonia, additional, Shaik, Imam, additional, Sharpe, Hannah R., additional, Sharrocks, Katherine, additional, Shaw, Robert, additional, Shea, Adam, additional, Sheehan, Emma, additional, Shepherd, Amy, additional, Shiham, Farah, additional, Silk, Sarah E., additional, Silva-Reyes, Laura, additional, Silveira, Lidiana B. T.D., additional, Silveira, Mariana B.V., additional, Singh, Nisha, additional, Sinha, Jaisi, additional, Skelly, Donal T., additional, Smith, Daniel C., additional, Smith, Nick, additional, Smith, Holly E., additional, Smith, David J., additional, Smith, Catherine C., additional, Soares, Airanuédida S., additional, Solórzano, Carla, additional, Sorio, Guilherme L., additional, Sorley, Kim, additional, Sosa-Rodriguez, Tiffany, additional, Souza, Cinthia M.C.D.L., additional, Souza, Bruno S.D.F., additional, Souza, Alessandra R., additional, Souza Lopez, Thamyres, additional, Sowole, Luciana, additional, Spencer, Alexandra J., additional, Spoors, Louise, additional, Stafford, Lizzie, additional, Stamford, Imogen, additional, Stein, Ricardo, additional, Stockdale, Lisa, additional, Stockwell, Lisa V., additional, Strickland, Louise H., additional, Stuart, Arabella, additional, Sturdy, Ann, additional, Sutton, Natalina, additional, Szigeti, Anna, additional, Tahiri-Alaoui, Abdessamad, additional, Tanner, Rachel, additional, Taoushanis, Carol, additional, Tarr, Alexander W., additional, Tarrant, Richard, additional, Taylor, Keja, additional, Taylor, Ursula, additional, Taylor, Iona Jennifer, additional, Taylor, Justin, additional, te Water Naude, Rebecca, additional, Templeton, Kate, additional, Themistocleous, Yrene, additional, Themistocleous, Andreas, additional, Thomas, Merin, additional, Thomas, Kelly, additional, Thomas, Tonia M., additional, Thombrayil, Asha, additional, Thompson, Julia, additional, Thompson, Fawziyah, additional, Thompson, Ameeka, additional, Thompson, Amber, additional, Thompson, Kevin, additional, Thornton-Jones, Viv, additional, Thotusi, Larissa H.S., additional, Tighe, Patrick J., additional, Tinoco, Lygia Accioly, additional, Tiongson, Gerlynn Ferreras, additional, Tladinyane, Bonolo, additional, Tomasicchio, Michele, additional, Tomic, Adriana, additional, Tonks, Susan, additional, Towner, James, additional, Tran, Nguyen, additional, Tree, Julia A., additional, Trillana, Gerry, additional, Trinham, Charlotte, additional, Trivett, Rose, additional, Truby, Adam, additional, Tsheko, Betty Lebogang, additional, Tubb, Philippa, additional, Turabi, Aadil, additional, Turner, Richard, additional, Turner, Cheryl, additional, Turner, Nicola, additional, Tyagi, Bhavya, additional, Ulaszewska, Marta, additional, Underwood, Benjamin R., additional, van Eck, Samual, additional, Varughese, Rachel, additional, Verbart, Dennis, additional, Verheul, Marije K., additional, Vichos, Iason, additional, Vieira, Taiane A., additional, Walker, Gemma, additional, Walker, Laura, additional, Wand, Matthew E., additional, Wardell, Theresa, additional, Warimwe, George M., additional, Warren, Sarah C., additional, Watkins, Bridget, additional, Watson, Marion E.E., additional, Watson, Ekaterina, additional, Webb, Stewart, additional, Webster, Angela, additional, Welch, Jessica, additional, Wellbelove, Zoe, additional, Wells, Jeanette H., additional, West, Alison J., additional, White, Beth, additional, White, Caroline, additional, White, Rachel, additional, Williams, Paul, additional, Williams, Rachel L., additional, Willingham, Silvia, additional, Winslow, Rebecca, additional, Woods, Danielle, additional, Woodyer, Mark, additional, Worth, Andrew T., additional, Wright, Danny, additional, Wroblewska, Marzena, additional, Yao, Andy, additional, Yim, Yee Ting Nicole, additional, Zambrano, Marina Bauer, additional, Zimmer, Rafael Leal, additional, Zizi, Dalila, additional, and Zuidewind, Peter, additional

Published
2021
Full Text
View/download PDF

43. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2

Author

Hatton, Catherine F, primary, Botting, Rachel A, additional, Dueñas, Maria Emilia, additional, Haq, Iram J, additional, Verdon, Bernard, additional, Thompson, Benjamin J, additional, Spegarova, Jarmila Stremenova, additional, Gothe, Florian, additional, Stephenson, Emily, additional, Gardner, Aaron I, additional, Murphy, Sandra, additional, Scott, Jonathan, additional, Garnett, James P, additional, Carrie, Sean, additional, Powell, Jason, additional, Khan, C M Anjam, additional, Huang, Lei, additional, Hussain, Rafiqul, additional, Coxhead, Jonathan, additional, Davey, Tracey, additional, Simpson, A John, additional, Haniffa, Muzlifah, additional, Hambleton, Sophie, additional, Brodlie, Malcolm, additional, Ward, Chris, additional, Trost, Matthias, additional, Reynolds, Gary, additional, and Duncan, Christopher J A, additional

Published
2021
Full Text
View/download PDF

44. T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

Author

Angyal, Adrienn, primary, Longet, Stephanie, additional, Moore, Shona, additional, Payne, Rebecca P., additional, Harding, Adam, additional, Tipton, Tom, additional, Rongkard, Patpong, additional, Ali, Mohammad, additional, Hering, Luisa M., additional, Meardon, Naomi, additional, Austin, James, additional, Brown, Rebecca, additional, Skelly, Donal, additional, Gillson, Natalie, additional, Dobson, Sue L., additional, Cross, Andrew, additional, Sandhar, Gurjinder, additional, Kilby, Jonathan A., additional, Tyerman, Jessica K., additional, Nicols, Alexander R., additional, Spegarova, Jarmila S., additional, Mehta, Hema, additional, Hornsby, Hailey, additional, Whitham, Rachel, additional, Conlon, Christopher P., additional, Jeffery, Katie, additional, Goulder, Philip, additional, Frater, John, additional, Dold, Christina, additional, Pace, Matthew, additional, Ogbe, Ane, additional, Brown, Helen, additional, Ansari, Azim M., additional, Adland, Emily, additional, Brown, Anthony, additional, Chand, Meera A., additional, Shields, Adrian, additional, Matthews, Philippa, additional, Hopkins, Susan, additional, Hall, Victoria Jane, additional, James, William, additional, Rowland-Jones, Sarah L., additional, Klenerman, Paul, additional, Dunachie, Susanna, additional, Richter, Alex G., additional, Duncan, Christopher J. A., additional, Barnes, Eleanor, additional, Carroll, Miles W., additional, Turtle, Lance, additional, de Silva, Thushan I., additional, and Consortium, PITCH, additional

Published
2021
Full Text
View/download PDF

45. Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine

Author

Payne, Rebecca P., primary, Longet, Stephanie, additional, Austin, James A., additional, Skelly, Donal, additional, Dejnirattisai, Wanwisa, additional, Adele, Sandra, additional, Meardon, Naomi, additional, Faustini, Sian, additional, Al-Taei, Saly, additional, Moore, Shona, additional, Tipton, Tom, additional, Hering, Luisa M., additional, Angyal, Adrienn, additional, Brown, Rebecca, additional, Gillson, Natalie, additional, Dobson, Sue L., additional, Amini, Ali, additional, Supasa, Piyada, additional, Cross, Andrew, additional, Sandhar, Gurjinder, additional, Kilby, Jonathan A., additional, Tyerman, Jessica K., additional, Nicols, Alexander R., additional, Altmann, Thomas, additional, Hornsby, Hailey, additional, Whitham, Rachel, additional, Phillips, Eloise, additional, Malone, Tom, additional, Hargreaves, Alexander, additional, Shields, Adrian, additional, Saei, Ayoub, additional, Foulkes, Sarah, additional, Stafford, Lizzie, additional, Johnson, Síle, additional, Wootton, Dan G., additional, Conlon, Christopher P., additional, Jeffery, Katie, additional, Matthews, Philippa, additional, Frater, John, additional, Deeks, Alexandra, additional, Dold, Christina, additional, Pollard, Andrew, additional, Brown, Anthony, additional, Rowland-Jones, Sarah L., additional, Mongkolsapaya, Juthathip, additional, Barnes, Eleanor, additional, Hopkins, Susan, additional, Hall, Victoria Jane, additional, Duncan, Christopher J. A., additional, Richter, Alex G., additional, Carroll, Miles W., additional, Screaton, Gavin R., additional, de Silva, Thushan I., additional, Turtle, Lance, additional, Klenerman, Paul, additional, Dunachie, Susanna, additional, and Consortium, The PITCH, additional

Published
2021
Full Text
View/download PDF

46. Efficacy of ChAdOx1 nCoV-19&nbsp;(AZD1222)&nbsp;Vaccine Against SARS-CoV-2 VOC&nbsp;202012/01&nbsp;(B.1.1.7)

Author

Emary, Katherine R. W., primary, Golubchik, Tanya, additional, Aley, Parvinder K., additional, Ariani, Cristina V., additional, Angus, Brian John, additional, Bibi, Sagida, additional, Blane, Beth, additional, Bonsall, David, additional, Cicconi, Paola, additional, Charlton, Sue, additional, Clutterbuck, Elizabeth, additional, Collins, Andrea M., additional, Cox, Tony, additional, Darton, Thomas, additional, Dold, Christina, additional, Douglas, Alexander D., additional, Duncan, Christopher J. A., additional, Ewer, Katie, additional, Flaxman, Amy, additional, Faust, Saul N., additional, Ferreira, Daniela M., additional, Feng, Shuo, additional, Finn, Adam, additional, Folegatti, Pedro M., additional, Fuskova, Michelle, additional, Galiza, Eva, additional, Goodman, Anna L., additional, Green, Catherine M., additional, Green, Christopher A., additional, Greenland, Melanie, additional, Hallis, Bassam, additional, Heath, Paul T., additional, Hay, Jodie, additional, Hill, Helen C., additional, Jenkin, Daniel, additional, Kerridge, Simon, additional, Lazarus, Rajeka, additional, Libri, Vincenzo, additional, Lillie, Patrick J., additional, Ludden, Catherine, additional, Marchevsky, Natalie G., additional, Minassian, Angela M., additional, McGregor, Alastair C., additional, Farooq Mujadidi, Yama, additional, Phillips, Daniel J., additional, Plested, Emma, additional, Pollock, Katrina M., additional, Robinson, Hannah, additional, Smith, Andrew, additional, Song, Rinn, additional, Snape, Matthew D., additional, Sutherland, Rebecca K., additional, Thomson, Emma C., additional, Toshner, Mark, additional, Turner, David P. J., additional, Vekemans, Johan, additional, Villafana, Tonya L., additional, Williams, Christopher J., additional, Hill, Adrian V. S., additional, Lambe, Teresa, additional, Gilbert, Sarah C., additional, Voysey, Merryn, additional, Ramasamy, Maheshi N., additional, Pollard, Andrew, additional, and Group, Oxford COVID Vaccine Trial, additional

Published
2021
Full Text
View/download PDF

47. Single Dose&nbsp;Administration,&nbsp;And&nbsp;The&nbsp;Influence Of&nbsp;The&nbsp;Timing Of&nbsp;The&nbsp;Booster Dose&nbsp;On Immunogenicity and Efficacy Of&nbsp;ChAdOx1 nCoV-19&nbsp;(AZD1222)&nbsp;Vaccine

Author

Voysey, Merryn, primary, Costa Clemens, Sue Ann, additional, Madhi, Shabir A., additional, Weckx, Lily Yin, additional, Folegatti, Pedro M., additional, Aley, Parvinder K., additional, Angus, Brian John, additional, Baillie, Vicky, additional, Barnabas, Shaun L., additional, Bhorat, Qasim E., additional, Bibi, Sagida, additional, Briner, Carmen, additional, Cicconi, Paola, additional, Clutterbuck, Elizabeth, additional, Collins, Andrea M., additional, Cutland, Clare, additional, Darton, Thomas, additional, Dheda, Keertan, additional, Douglas, Alexander D., additional, Duncan, Christopher J. A., additional, Emary, Katherine R. W., additional, Ewer, Katie, additional, Flaxman, Amy, additional, Fairlie, Lee, additional, Faust, Saul N., additional, Feng, Shuo, additional, Ferreira, Daniela M., additional, Finn, Adam, additional, Galiza, Eva, additional, Goodman, Anna L., additional, Green, Catherine M., additional, Green, Christopher A., additional, Greenland, Melanie, additional, Hill, Catherine, additional, Hill, Helen C., additional, Hirsch, Ian, additional, Izu, Alane, additional, Jenkin, Daniel, additional, Kerridge, Simon, additional, Koen, Anthonet, additional, Kwatra, Gaurav, additional, Lazarus, Rajeka, additional, Libri, Vincenzo, additional, Lillie, Patrick J., additional, Marchevsky, Natalie G., additional, Marshall, Richard P., additional, Mendes, Ana Verena Almeida, additional, Milan, Eveline P., additional, Minassian, Angela M., additional, McGregor, Alastair C., additional, Farooq Mujadidi, Yama, additional, Nana, Anusha, additional, Payadachee, Sherman D., additional, Phillips, Daniel J., additional, Pittella, Ana, additional, Plested, Emma, additional, Pollock, Katrina M., additional, Ramasamy, Maheshi N., additional, Robinson, Hannah, additional, Schwarzbold, Alexandre V., additional, Smith, Andrew, additional, Song, Rinn, additional, Snape, Matthew D., additional, Sprinz, Eduardo, additional, Sutherland, Rebecca K., additional, Thomson, Emma C., additional, Torok, Mili, additional, Toshner, Mark, additional, Turner, David P. J., additional, Vekemans, Johan, additional, Villafana, Tonya L., additional, White, Thomas, additional, Williams, Christopher J., additional, Hill, Adrian V. S., additional, Lambe, Teresa, additional, Gilbert, Sarah C., additional, Pollard, Andrew, additional, and Group, Oxford COVID Vaccine Trial, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results